Cargando…
Assessment of infectivity and the impact on neutralizing activity of immune sera of the COVID-19 variant, CAL.20C
Autores principales: | Zhou, Zhongcheng, Du, Peng, Yu, Meixing, Baptista-Hon, Daniel T., Miao, Man, Xiang, Andy P., Lau, Johnson Yiu-Nam, Li, Gen, Zhang, Kang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313410/ https://www.ncbi.nlm.nih.gov/pubmed/34315848 http://dx.doi.org/10.1038/s41392-021-00695-0 |
Ejemplares similares
-
The SARS-CoV-2 spike L452R-E484Q variant in the Indian B.1.617 strain showed significant reduction in the neutralization activity of immune sera
por: Li, Gen, et al.
Publicado: (2021) -
Homologous or heterogenous vaccination boosters enhance neutralizing activities against SARS‐CoV‐2 Omicron BA.1 variant
por: Zhou, Zhongcheng, et al.
Publicado: (2022) -
Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant
por: Li, Gen, et al.
Publicado: (2022) -
Reduced neutralization of SARS-CoV-2 B.1.617 variant by convalescent and vaccinated sera
por: Hu, Jie, et al.
Publicado: (2021) -
Neutralization of ARCoV-induced sera against SARS-CoV-2 variants
por: Li, Xiao-Feng, et al.
Publicado: (2022)